or
forgot password
  • cancer clinical trials in pittsburgh, PA

  • Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Western Pennsylvania Hospital The Western Pennsylvania Hospi
    Pittsburgh, Pennsylvania 15224
    Myelodysplastic Syndromes
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Breast Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    UPMC Cancer Center at Magee-Womens Hospital

    Trial Locations
    UPMC Cancer Center at Magee-Womens Hospital
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Endometrial Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Allegheny Cancer Center at Allegheny General Hospital
    Pittsburgh, Pennsylvania 15212
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Western Pennsylvania Hospital

    Trial Locations
    Western Pennsylvania Hospital
    Magee-Womens Hospital - University of Pittsburgh Medical Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    UPMC Cancer Centers

    Trial Locations
    UPMC Cancer Centers
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
    Department of Medical Genetics, Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Gaucher Disease
    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
    GSK Investigational Site
    Pittsburgh, Pennsylvania 15213
    Cancer
    Multicenter Hologic Tomosynthesis Study
    Magee Women's Hospital
    Pittsburgh, Pennsylvania 15213
    Breast Cancer
    Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Intracranial Meningioma
    Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
    University of Pittsburgh Medical Center/University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Melanoma
    Hypofractionated SBRT For Prostate Cancer
    UPMC Shadyside Radiation Oncology
    Pittsburgh, Pennsylvania 15232
    Prostate Cancer
    A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric Cancer
    Red Cell Storage Duration Study
    University of Pittsburgh Presbyterian and Shadyside

    Trial Locations
    University of Pittsburgh Presbyterian and Shadyside
    UPMC-Mercy Hospital
    Cardiac Surgery, Erythrocyte Transfusion
    A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
    University of Pittsburgh Cancer Institute Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication,, Advanced Solid Tumors With FGFR3 Mutation
    Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Pittsburgh, Pennsylvania 15224-1791
    Leukemia
    Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Pittsburgh, Pennsylvania 15224-1791
    Leukemia
    Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Refractory Cutaneous T-cell Lymphoma
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2)
    Pittsburgh, Pennsylvania 15232
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
    Allegheny Cancer Center at Allegheny General Hospital

    Trial Locations
    Allegheny Cancer Center at Allegheny General Hospital
    University of Pittsburgh
    NSABP Foundation, Inc.
    Breast Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Allegheny Cancer Center at Allegheny General Hospital
    Pittsburgh, Pennsylvania 15212
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Western Pennsylvania Hospital

    Trial Locations
    Western Pennsylvania Hospital
    Magee-Womens Hospital of UPMC
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast, Malignant Melanoma
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Western Pennsylvania Cancer Institute /Western Penn Hospital Western Pann. Cancer Inst.
    Pittsburgh, Pennsylvania 15224
    Multiple Myeloma
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    University of Pittsburgh Cancer Institute Dept of Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Melanoma
    Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
    Magee-Womens Hospital of UPMC
    Pittsburgh, Pennsylvania 15213
    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Allegheny Cancer Center
    Pittsburgh, Pennsylvania 15212-4772
    Renal Cell Carcinoma
    Aspirin in Reducing Events in the Elderly
    University of Pittsburgh Health Sciences Research Center
    Pittsburgh, Pennsylvania
    Functional Disability, Dementia, Heart Disease, Stroke, Cancer, Bleeding
    Dendritic Cells (DC) Vaccine for Metastatic Melanoma
    Upmc Upci Hcc
    Pittsburgh, Pennsylvania 15232
    Metastatic Melanoma
    Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum
    UPMC St. Margaret
    Pittsburgh, Pennsylvania 15215
    Breast Cancer
    Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
    UPMC Cancer Centers - Drake

    Trial Locations
    UPMC Cancer Centers - Drake
    UPMC Cancer Centers - St. Margaret's
    UPMC Cancer Centers - Hillman Cancer Center
    UPMC Cancer Centers - Passavant
    VA Healthcare System - 646
    Myeloma
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Allegheny Cancer Center at Allegheny General Hospital
    Pittsburgh, Pennsylvania 15212
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
    University of Pittsburgh, Department of Medicine.
    Pittsburgh, Pennsylvania 15232
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    The Western Pennsylvania Hospital

    Trial Locations
    The Western Pennsylvania Hospital
    UPCI Hillman Cancer Center
    Multiple Myeloma
    Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma